Drug Profile
Ciprofloxacin otic foam - Eledon Pharmaceuticals
Alternative Names: Ciprofloxacin 0.3% otic foam; Foam Otic Cipro; FoamOtic Externa; OP-01 - Eledon Pharmaceuticals; OP-01 Foam; OP-0101Latest Information Update: 04 Dec 2021
Price :
$50
*
At a glance
- Originator Otic Pharma
- Developer Novus Therapeutics
- Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
- Mechanism of Action DNA gyrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Otitis externa
Most Recent Events
- 04 Jan 2021 Novus Therapeutics is now called Eledon Pharmaceuticals
- 10 May 2017 Tokai Pharmaceuticals has merged with Otic Pharma and subsequently changed its name to Novus Therapeutics
- 03 Jan 2017 Ciprofloxacin otic foam is still in phase II trials for Otitis Externa (OticPharma pipeline, January 2017)